Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-018092
Filing Date
2019-05-09
Accepted
2019-05-09 17:02:32
Documents
57
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q cytk-10q_20190331.htm 10-Q 1641781
2 EX-31.1 cytk-ex311_9.htm EX-31.1 9942
3 EX-31.2 cytk-ex312_8.htm EX-31.2 10116
4 EX-31.3 cytk-ex313_6.htm EX-31.3 9989
5 EX-32.1 cytk-ex321_7.htm EX-32.1 9232
  Complete submission text file 0001564590-19-018092.txt   5190386

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cytk-20190331.xml EX-101.INS 1056504
7 XBRL TAXONOMY EXTENSION SCHEMA cytk-20190331.xsd EX-101.SCH 45860
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cytk-20190331_cal.xml EX-101.CAL 52627
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cytk-20190331_def.xml EX-101.DEF 114894
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE cytk-20190331_lab.xml EX-101.LAB 298834
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cytk-20190331_pre.xml EX-101.PRE 217479
Mailing Address 280 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 280 EAST GRAND AVENUE . SOUTH SAN FRANCISCO CA 94080 (650) 624-3000
CYTOKINETICS INC (Filer) CIK: 0001061983 (see all company filings)

EIN.: 943291317 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50633 | Film No.: 19811565
SIC: 2834 Pharmaceutical Preparations